Treatment of hepatitis C
Bourlière, M.; Khaloun, A.; Castellani, P.; Portal, I.; Ansaldi, C.; Adhoute, X.; Pol, S.
La Revue du Praticien 61(1): 55-60
2011
ISSN/ISBN: 0035-2640 PMID: 21452544 Document Number: 649389
Hepatitis C treatment has made a lot of progress in the last two decades. Treatment with pegylated interferon and ribarin is associated with sustained virological response in more than 50% of patients. This improvement is due in one part to the adaptation of treatment dose and duration according to genotype, liver fibrosis and response-guided therapy, fibrosis in another part to a better pretreatment management of co-morbidities and a better prevention and management of side effects. New direct antiviral agents will become soon available and will lead to an improvement of sustained virological response with maybe more complex therapy leading to a new management of patients.